Pharma

Dec 21 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #biocon #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Sep 9 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #pharmaceutical #distribution #companies

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Aug 18 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #bioniche #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

May 1 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #buy-pharma.com

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Apr 22 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #bsp #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Apr 5 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #arena #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Feb 5 2017

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #specialty #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Oct 29 2016

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug #altana #pharma

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …

Sep 21 2016

Allergan’s Actavis recalls nearly 600, 000 bottles of ADHD drug

#actavis pharma manufacturing # Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse. That means that Allergan ($AGN) is responsible for the recall of more than 50 lots, consisting of nearly 600,000 bottles, of its copy of the ADHD drug Adderall. According to the most recent FDA Enforcement Report, Actavis is voluntarily recalling 54 lots involving four different dose forms of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets after they failed tests …